200 mg IG573 (Pregabalin 200 mg)
Pill with imprint 200 mg IG573 is Orange, Capsule-shape and has been identified as Pregabalin 200 mg. It is supplied by Cipla USA, Inc..
Pregabalin is used in the treatment of neuropathic pain; fibromyalgia; diabetic peripheral neuropathy; neuralgia; postherpetic neuralgia and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Pregabalin 200 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for 200 mg IG573
Pregabalin
- Imprint
- 200 mg IG573
- Strength
- 200 mg
- Color
- Orange
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Gamma-aminobutyric acid analogs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 69097-0959
More about pregabalin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1363 Reviews
- Drug class: gamma-aminobutyric acid analogs
- FDA Alerts (2)
Consumer resources
- Patient Information
- Pregabalin (Advanced Reading)
- Pregabalin Extended-Release Tablets
- Pregabalin Capsules
- Pregabalin Oral Solution
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.